According to IHC data on tumour tissues, we found that LGALS3BP is highly expressed at both mRNA, intracellular and secreted protein levels in all patient‐derived GBM cell lines tested (Fig. S3A–C). This evidence concerns the gene LGALS3BP and neoplasm.